Transform Your Health with Our Weight Management Membership

Q: Are these prices guaranteed?

No. The prices shown reflect manufacturer and manufacturer-linked savings programs, which can change. Always confirm current pricing directly with the manufacturer or your pharmacy.

Q: How is the $50/month Medicare option different from these prices?

The $50 per month figure is the Medicare GLP-1 Bridge, available only to eligible Medicare members with Part D beginning July 1, 2026. The prices on this page are self-pay (cash) pricing for everyone else. Take our eligibility check to see if the Bridge applies to you.

Q: Can I use GoodRx or pharmacy coupons?

Often yes, especially for generics like phentermine or phentermine/topiramate. Brand-name GLP-1s usually use the manufacturer savings programs shown on this page rather than GoodRx. Ask us and we help you find the lowest price.

Lose weight, gain energy, and feel confident — with a personalized, medically guided program that works.

Weight-Health Medication Self-Pay Pricing Guide

A clear, centralized look at cash-pay pricing for select obesity medications — so you can compare options and choose what fits your health, goals, and budget.

We treat obesity as a chronic disease and use medication when it’s appropriate and affordable — always chosen together with your clinician.

New for Medicare members

Get GLP-1 medication for $50/month through Medicare

Starting July 1, 2026, eligible Medicare members with Part D can access certain GLP-1 medications for as little as $50 a month through the Medicare GLP-1 Bridge. Not sure if you qualify? Take our quick eligibility check.

Check if I qualify →

Overview of obesity medications

Obesity medications fall into several categories based on how they work, how they are taken, how much average weight loss they tend to produce, and which patients they may suit best. The right choice depends on your medical history, treatment goals, affordability, side effects, and personal preference — decided together with your clinician.

Request an appointment with a CFMA clinician to review your options and decide what makes the most sense for your health and your budget.

Request an appointment

GLP-1 injections

GLP-1 · semaglutide injection

Wegovy®

Prices reflect available NovoCare® self-pay program pricing.

Dose	Self-pay	Notes
0.5 mg / 0.5 mL	$349	$199 for first 2 months
1 mg / 0.5 mL	$349	—
1.7 mg / 0.75 mL	$349	—
2.4 mg / 0.75 mL	$349	Maintenance dose
HD 7.2 mg / 0.75 mL	$399	—

What the research shows: In the STEP-1 trial, adults with overweight or obesity taking semaglutide 2.4 mg weekly lost an average of 15% of body weight after 68 weeks; about 1 in 3 lost 20% or more.¹

GLP-1 · semaglutide injection (off-label)

Ozempic®

Ozempic® is not FDA-approved specifically for obesity, but may be prescribed off-label when medically appropriate. For some patients it can be a more affordable way to access semaglutide. Prices reflect available NovoCare® self-pay program pricing.

Dose	Self-pay	Notes
0.25 / 0.5 mg / 3 mL	$349	$199 for first 2 months
1 mg / 3 mL	$349	—
2 mg / 3 mL	$499	—

What the research shows: In STEP-1, adults taking semaglutide 2.4 mg weekly lost an average of 15% of body weight after 68 weeks; about 1 in 3 lost 20% or more.¹

GLP-1/GIP · tirzepatide

Zepbound®

Price for 1 month (1 box / 4 doses).

Dose	Self-pay	Form
2.5 mg / 0.5 mL	$299	KwikPen® & vial
5 mg / 0.5 mL	$399	KwikPen® & vial
7.5 mg / 0.5 mL	$449	KwikPen® & vial
10 mg / 0.5 mL	$449	KwikPen® & vial
12.5 mg / 0.5 mL	$449	KwikPen® & vial
15 mg / 0.5 mL	$449	KwikPen® & vial
2.5–15 mg (pen)	$499	Pricing available with coupon

What the research shows: In a 72-week trial of adults without diabetes, the share achieving at least 25% body-weight loss was:

5 mg: 15.3%
10 mg: 32.3%
15 mg: 36.2%
Placebo: 1.5%

Oral GLP-1 medications

Oral GLP-1 · oral semaglutide

Wegovy® pill

Prices reflect available NovoCare® self-pay program pricing.

Dose	Self-pay	Notes
1.5 mg	$149	Pricing will change after August 2026
4 mg	$149	Pricing will change after August 2026
9 mg	$299	—
25 mg	$299	—

What the research shows: In OASIS 4, oral semaglutide 25 mg once daily showed 16.6% mean weight loss in adults with obesity or overweight plus a comorbidity, when treatment was adhered to.³

Oral GLP-1 · orforglipron

Foundayo™

Dose	Self-pay	Notes
0.8 mg	$149	—
2.5 mg	$199	—
5.5 mg	$299	—
9 mg	$299	—
14.5 mg	$299	—
17.2 mg	$299	—

What the research shows: In a 72-week study of adults without diabetes, average weight loss was 7.4% (17.2 lb) at 5.5 mg, 8.3% (18.9 lb) at 9 mg, and 11.1% (24.9 lb) at 17.2 mg, vs 2.1% (5.3 lb) for placebo.⁶

Oral combination medications

Oral combination · phentermine / topiramate ER

Qsymia® & generic phentermine/topiramate ER

Pricing varies by pharmacy and savings program — ask us for current options. Note: Qsymia® and generic phentermine/topiramate ER may not be prescribable via telemedicine in certain states.

What the research shows: In CONQUER, patients on Qsymia® 7.5/46 mg lost about 7.8% of body weight and those on 15/92 mg about 9.8%, vs ~1.2% for placebo. About 62% (7.5/46) and 70% (15/92) achieved at least 5% weight loss, vs ~21% for placebo.⁴

Oral combination · naltrexone / bupropion

Contrave®

If you do not have insurance coverage for Contrave®, the manufacturer indicates patient cost may be capped at no more than $199.

What the research shows: Adults taking Contrave® with diet and exercise lost more than lifestyle changes alone — 5.4% (12 lb) vs 1.3% (3 lb) in COR-I, and 8.1% (18 lb) vs 4.9% (11 lb) in COR-BMOD.⁵

Established, lower-cost options

Generic · appetite suppressants & off-label

Phentermine, diethylpropion & metformin

Tried-and-true, budget-friendly options we may use on their own or alongside other therapies when appropriate.

Phentermine — a short-term appetite suppressant and one of the most affordable prescription options.
Diethylpropion — another low-cost appetite suppressant, similar to phentermine.
Metformin (off-label) — inexpensive and often helpful when insulin resistance is part of the picture.

These are generally low-cost generics; actual pricing varies by pharmacy — ask us about cash pricing or check GoodRx. Note: phentermine and diethylpropion are controlled substances and may not be prescribable via telemedicine in some states.

Safety, side effects & how we help

GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide) are effective tools, but they aren’t right for everyone and they do have side effects. Here’s what to know — and how we support you through it.

Who should not take GLP-1 / GIP medications

These medications carry a boxed warning and may not be appropriate for everyone. Tell your clinician if any of the following apply to you:

A personal or family history of medullary thyroid carcinoma (MTC), or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
A prior serious allergic reaction to the medication or any of its ingredients
A history of pancreatitis, gallbladder disease, or a severe gastrointestinal condition such as gastroparesis
Pregnancy, planning pregnancy, or breastfeeding
Type 1 diabetes, or use of insulin or sulfonylureas (risk of low blood sugar)

This is not a complete list. Your clinician will review your full medical history to decide whether these medications are safe for you.

Side effects

Common side effects — and how we help

Most side effects are gastrointestinal and tend to be strongest when you start or increase a dose, then ease over time. The most common are nausea, vomiting, diarrhea, constipation, reflux, and abdominal discomfort.

We reduce these by titrating your dose slowly, adjusting your plan, and coaching practical strategies — smaller, blander meals, staying hydrated, prioritizing protein, and timing your dose. Rare but serious risks (pancreatitis, gallbladder problems, dehydration-related kidney strain, or low blood sugar) are part of what we monitor at every visit.

Hair loss

What about hair loss?

Some patients notice temporary hair thinning during rapid weight loss. This is usually telogen effluvium — a shedding pattern driven by the rapid change and shifts in nutrition rather than the medication itself — and it typically recovers. We help guard against it by keeping weight loss at a healthy pace, ensuring adequate protein and key nutrients, and tracking your body composition so you lose fat while preserving lean mass.

How we help you navigate treatment

You’re not doing this alone. We personalize your medication and dose, manage side effects proactively, monitor your labs and body composition, support your nutrition, and adjust the plan as you go — so treatment stays safe, tolerable, and effective.

Request an appointment

Choosing the right option, with guidance

Choosing an obesity medication isn't about picking the biggest number. At CFMA Weight Management we help you think through the whole picture.

Your goals

Different medications produce different average results. Some patients aim for a 5–10% reduction; others need an approach more likely to support 10–15% or 15%+ total body-weight loss.

Your budget

Prices vary widely. Manufacturer savings programs, cash-pay options, and insurance coverage all change what a medication actually costs.

Side effects & tolerability

Each category has its own profile — nausea, reflux, or other GI symptoms for some; dry mouth, tingling, mood or sleep changes for others. Treatment should match what's realistic for you to tolerate.

Your lifestyle

Some patients prefer a weekly injection, others a daily pill. Some need help with appetite, others with cravings or reward-based eating. Matching treatment to daily life supports long-term success.

A note from our team

Medication can be a powerful tool, but it's only one part of obesity care. We treat obesity as a chronic disease and consider the whole person — biology, medical history, eating patterns, movement, sleep, stress, body composition, and long-term goals. Our job isn't to push one medication over another; it's to help you choose a plan that's safe, sustainable, and aligned with your life.

Ready to talk through your options?

Request an appointment with CFMA

Pricing FAQ

Are these prices guaranteed?

No — the prices shown reflect manufacturer and manufacturer-linked savings programs, which can change. Always confirm current pricing directly with the manufacturer or your pharmacy.

Will my insurance cover these, or do I pay cash?

It depends on your plan. We recommend calling your insurer; you can also check coverage with the manufacturer tools for Wegovy and Zepbound. If you’ll be paying out of pocket, the cash-pay prices above are your guide — and we’ll help you find the most affordable path.

How is the $50/month Medicare option different from these prices?

The $50/month figure is the Medicare GLP-1 Bridge — available only to eligible Medicare members with Part D, beginning July 1, 2026. The prices above are self-pay (cash) pricing for everyone else. Take our eligibility check to see if the Bridge applies to you.

Can I use GoodRx or pharmacy coupons?

Often, yes — especially for generics like phentermine or phentermine/topiramate. Brand-name GLP-1s usually use the manufacturer savings programs shown above rather than GoodRx. Ask us and we’ll help you find the lowest price.

¹ STEP-1: semaglutide 2.4 mg weekly, ~15% average loss at 68 weeks; ~1 in 3 lost ≥20%.

² SURMOUNT-1: tirzepatide average loss 15.4% (5 mg), 19.9% (10 mg), 22.9% (15 mg) at 72 weeks vs 2.1% placebo.

³ OASIS 4: oral semaglutide 25 mg daily, 16.6% mean loss in adults with obesity/overweight + ≥1 comorbidity when adhered to.

⁴ CONQUER: Qsymia® 7.5/46 mg ~7.8%; 15/92 mg ~9.8% vs ~1.2% placebo at 56 weeks.

⁵ COR-BMOD: Contrave® 8.1% vs 4.9% with lifestyle alone. COR-I: 5.4% vs 1.3%.

⁶ ATTAIN-1: orforglipron dose-dependent loss 7.4%–11.1% vs 2.1% placebo in adults without diabetes.

All pricing reflects manufacturer-provided or manufacturer-linked information and may change. Confirm current pricing with the manufacturer or participating pharmacy. This page is educational and is not medical advice or a coverage determination.

Weight Management

Dr. Reller is board certified by the American Board of Obesity Medicine and a member of the Obesity Medicine Association. Christina Taylor, ARPN, has also received a Certificate of Advanced Education in Obesity Medicine through the Obesity Medicine Association.

We believe obesity is a chronic disease that is relapsing and remitting and needs to be managed like other chronic diseases such as asthma and high blood pressure. Most likely, proper management will require a dedicated weight management visit to ensure enough time to properly discuss barriers and treatment. If you are not our primary care patient, we can still see you and discuss payment plans or possibly use your insurance if obesity management is covered or if you have comorbidities and we are in-network.

We do utilize anti-obesity medications if necessary and if covered or affordable for our patients. These include metformin (off-label), phentermine, diethylpropion, semaglutide (Ozempic - diabetes only, Wegovy), tirzepatide (Mounjaro - diabetes only, Zepbound), Contrave, Qsymia. We do not typically use Meal Replacement Programs but can make recommendations if needed. Our Weight Management Program is Membership Only. Please see our flyer regarding the Weight Management Membership.